glp-1 deficiency therapy is becoming a widespread pharmaceutical treatment for obesity and type 2 diabetes, but there are side effects. Many users develop deficiencies in critical nutrients like vitamin D, iron, and B GLP-1 vitamin guide: every nutrient

Semaglutide was associated with gastrointestinal adverse events (nausea, vomiting, diarrhea, constipation) which were of mild to moderate severity, short duration, and resolved without treatment discontinuation ( Notably, a recent systematic review showed that compared to other semaglutide doses and GLP-1 RAs, 2.4 mg semaglutide had the greatest effect on weight reduction, controlling glucose level, and reducing BP

The drugs benefits are clear, but their vast benefits could also be a double-edged sword

Jump to: Understanding GLP-1 medications | Commercial GLP-1 patches | The science of transdermal delivery | GLP-1 injections: evidence and efficacy | Safety comparison | UK considerations | Frequently asked questions | Take home message There is no clinical evidence that GLP-1 patches work for weight loss

Up to 24.2% body weight reduction over 48 weeks